Protease-activated receptor (PAR)

Protease‑activated receptors are a subfamily of G protein-coupled receptors that are uniquely activated by proteolytic cleavage of their extracellular N-terminal domain. This cleavage exposes a new “tethered ligand” sequence that binds intramolecularly to activate the receptor. There are four known mammalian members: **PAR1**, **PAR2**, **PAR3**, and **PAR4**. These receptors play critical roles in mediating cellular responses to extracellular proteases such as thrombin, trypsin, factor Xa, and others derived from coagulation cascades or inflammatory cells. They are highly expressed on platelets but also found on endothelial cells, immune cells, neurons, smooth muscle cells, epithelial tissues lining the gut and airways—and even some cancer cells. Their biological functions include regulating hemostasis/thrombosis via platelet activation (**especially through PAR1 and PAR4**), modulating inflammation through immune cell signaling (**notably via PAR2**), influencing vascular tone/endothelial function (**via multiple family members**), contributing to tissue repair/remodeling processes—and participating in pathological conditions like cardiovascular diseases, cancer progression/metastasis/invasion potential,[3] chronic inflammation,[6] infection responses,[5] neurodegeneration,[3] fibrosis,[8] among others. Therapeutically targeted mainly for their role in thrombosis prevention—with drugs like vorapaxar inhibiting platelet aggregation by blocking thrombin-induced activation—their broad physiological impact means safety concerns must be carefully managed.[7][5][2]

Other names

PARProtease activated receptorProteinase-activated receptorThrombin receptor (for PAR1, sometimes used)F2R (PAR1 gene)F2RL1 (PAR2 gene)F2RL2 (PAR3 gene)F2RL3 (PAR4 gene)

– Antagonism of proteolytic activation by blocking the tethered ligand site or allosteric sites on the receptor, preventing downstream G protein signaling and platelet aggregation or inflammatory responses[7][5]. – Agonist peptides can mimic the exposed tethered ligand to activate signaling in experimental settings.